Printing of protein microarrays via a capillary-free fluid jetting mechanism

被引:83
作者
Barron, JA
Young, HD
Dlott, DD
Darfler, MM
Krizman, DB
Ringeisen, BR
机构
[1] USN, Res Lab, Washington, DC 20375 USA
[2] Univ Illinois, Urbana, IL 61801 USA
[3] Express Pathol Inc, Gaithersburg, MD USA
关键词
biological laser printing; protein microarray; protein printing;
D O I
10.1002/pmic.200401294
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Current proteomics experiments rely upon printing techniques such as ink jet, pin, or quill arrayers that were developed for the creation of cDNA microarrays. These techniques often do not meet the requirements needed for successful spotting of proteins to perform high-throughput, array-based proteomic profiling. Biological laser printing (BioLP) is a spotting technology that does not rely on solid pins, quill pins, or capillary-based fluidics. The non-contact mechanism of BioLP utilizes a focused laser pulse to transfer protein solutions, thereby eliminating the potential for orifice clogging, air bubbles, and unnecessary volume loss potentially encountered in commercially available spotting technologies. The speed and spot-to-spot reproducibility of BioLP is comparable to other techniques, while the minimum spot diameter and volume per printed droplet is significantly less at 30 gm and similar to 500 fL, respectively. The transfer of fluid by BioLP occurs through a fluid jetting mechanism, as observed by high-speed images of the printing process. Arraying a solution of BSA with subsequent immunodetection demonstrates the reproducible spotting of protein in an array format with CVs of <3%. Printing of the enzyme alkaline phosphatase followed by a positive reaction with a colorimetric substrate demonstrates that functional protein can be spotted using this laser-based printer.
引用
收藏
页码:4138 / 4144
页数:7
相关论文
共 26 条
  • [11] Knezevic V, 2001, PROTEOMICS, V1, P1271, DOI 10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO
  • [12] 2-6
  • [13] LEE IYS, 1992, J IMAGING SCI TECHN, V36, P180
  • [14] MacBeath G, 2000, SCIENCE, V289, P1760
  • [15] Madoz-Gúrpide J, 2001, PROTEOMICS, V1, P1279, DOI 10.1002/1615-9861(200110)1:10<1279::AID-PROT1279>3.0.CO
  • [16] 2-W
  • [17] Analyzing antibody specificity with whole proteome microarrays
    Michaud, GA
    Salcius, M
    Zhou, F
    Bangham, R
    Bonin, J
    Guo, H
    Snyder, M
    Predki, PF
    Schweitzer, BI
    [J]. NATURE BIOTECHNOLOGY, 2003, 21 (12) : 1509 - 1512
  • [18] Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays
    Nishizuka, S
    Charboneau, L
    Young, L
    Major, S
    Reinhold, WC
    Waltham, M
    Kouros-Mehr, H
    Bussey, KJ
    Lee, JK
    Espina, V
    Munson, PJ
    Petricoin, E
    Liotta, LA
    Weinstein, JN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) : 14229 - 14234
  • [19] Shadowgraphic imaging of the sub-ps laser-induced forward transfer process
    Papazoglou, DG
    Karaiskou, A
    Zergioti, I
    Fotakis, C
    [J]. APPLIED PHYSICS LETTERS, 2002, 81 (09) : 1594 - 1596
  • [20] Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
    Paweletz, CP
    Charboneau, L
    Bichsel, VE
    Simone, NL
    Chen, T
    Gillespie, JW
    Emmert-Buck, MR
    Roth, MJ
    Petricoin, EF
    Liotta, LA
    [J]. ONCOGENE, 2001, 20 (16) : 1981 - 1989